Community thrombolysis in the Coromandel region. Audit of the "Cardiac Events in the Coromandel-Assessment Strategy

C Nunn1, J Lennane, G Marriott

  • 1Department of Cardiology, Waikato Hospital, Hamilton.

Insights

Community thrombolysis significantly reduced treatment times for acute myocardial infarction (MI) patients in New Zealand. This pilot program proved logistically feasible, improving patient outcomes by enabling faster access to critical care.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Health Services Research

Background:

  • Acute myocardial infarction (MI) requires rapid intervention to minimize cardiac damage.
  • Geographic remoteness can delay access to time-sensitive treatments like thrombolysis.
  • A pilot program was initiated in the Coromandel region to address treatment delays.

Purpose of the Study:

  • To audit the feasibility and impact of a community thrombolysis pilot program.
  • To evaluate the time efficiency of pre-hospital thrombolysis compared to in-hospital treatment.

Main Methods:

  • Nineteen patients in the Coromandel region received community thrombolysis (Retelapse) between July 1998 and December 1999.
  • ECGs were digitally transmitted for remote review by a cardiology registrar.
  • Treatment times and patient demographics were prospectively recorded; outcomes were reviewed via chart analysis. A historical cohort receiving in-hospital thrombolysis was used for comparison.

Main Results:

  • Community thrombolysis was administered to 19 patients, with no adverse events during transport or hospital stay.
  • Median time from pain onset to thrombolysis was 135 minutes, a 135-minute reduction compared to the historical cohort (median 270 minutes).
  • This time reduction was statistically significant (p=0.0003).

Conclusions:

  • Community thrombolysis is logistically feasible in the New Zealand context.
  • This approach significantly reduces treatment delays for acute myocardial infarction (MI) patients.
  • The findings support the expansion of community-based thrombolysis programs.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...